For the Inventor, By the Inventor

Enter assignee name

Daejeon, South Korea

Y-biologics Inc.

USPTO Granted Patents = 12

CIPO Patents = 11

Trademarks = 1

Forward Citations = 8

Loading Chart...

Loading Chart...

68 inventors (with patents filed for the assignee):

Young Woo Park (12 out of 40 patents)

Bum-chan Park (10 out of 11 patents)

Jae Eun Park (6 out of 8 patents)

4. Seok Ho Yoo (5 out of 9 patents)

5. Young-Gyu Cho (4 out of 5 patents)

6. Seil Jang (4 out of 5 patents)

7. Jung Chae Lim (4 out of 4 patents)

8. Si Hyung Lee (3 out of 3 patents)

9. Youngja Song (3 out of 3 patents)

10. Gi Sun Baek (3 out of 3 patents)

11. Hyun Mi Lee (3 out of 3 patents)

12. Ji-Young Shin (2 out of 2 patents)

13. Sunha Yoon (2 out of 2 patents)

14. Yunseon Choi (2 out of 2 patents)

15. Jisu Lee (2 out of 2 patents)

12 patents: Sort by Forward Citations

1. 12168060 - Antibody-drug conjugates comprising anti-B7-H3 antibodies (2024-12-17),

2. 12139530 - Bispecific antibody specifically binding to IL-17A and TNF-α (2024-11-12),

3. 11945864 - Monoclonal antibody specifically binding to LAG-3 and use thereof (2024-04-02),

4. 11306141 - Antibody against human DLK1 and use thereof (2022-04-19),

5. 11248048 - Antibody to programmed cell death 1 (PD-1) and use thereof (2022-02-15),

6. 10919966 - Antibody to programmed death-ligand 1 (PD-L1) and use thereof (2021-02-16),

7. 10836833 - Cell engaging binding molecules (2020-11-17),

8. 10654944 - Cell engaging binding molecules (2020-05-19),

9. 10640576 - Cell engaging binding molecules (2020-05-05),

10. 10633458 - Cell engaging binding molecules (2020-04-28),

11. 10448662 - Composition for preventing or treating fatty liver or insulin resistance syndrome including extracellular domain of delta-like 1 homolog (2019-10-22),

12. 9631020 - Anti-c-Met antibody having HGF activity and use thereof (2017-04-25),

Y-biologics Inc. is a biotechnology company specializing in the development of novel therapeutics for cancer and other diseases. Our innovative approach combines cutting-edge research in immunology and biologics to create targeted treatments that improve patient outcomes. With a focus on precision medicine, we are dedicated to advancing the field of biotechnology through our groundbreaking discoveries and collaborations with leading researchers and institutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

12 Patents

#47 in Daejeon

#894 in South Korea

#46,665 in the World

Daejeon, South Korea

Y-biologics Inc.

Forward Citations = 8

68 inventors:

Young Woo Park (12 out of 40 patents)

Bum-chan Park (10 out of 11 patents)

Jae Eun Park (6 out of 8 patents)

4. Seok Ho Yoo (5 out of 9 patents)

5. Young-Gyu Cho (4 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…